Cencora, Inc.

NYSE:COR

Medical - Distribution

Healthcare
$348.31 -2.04%

-$5.65 today

Market cap
$66.47B
Beta
0.59
P/E (TTM)
20.7
EPS (TTM)
$13.10
Dividend yield
0.87%
52W Low $244.82High $377.54

Volume 1.20M

Average 1.78M

COR Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Cencora, Inc.NYSE: COR

Net Receivables · Q3 FY2026 · quarter ended Jun 2026

Net receivables rises 3.6% from a year ago

Net receivables stood at $25.45B at the end of Q3 FY2026, up 3.6% from a year earlier and up 2.2% from the prior quarter. Over 3 fiscal years it compounded at +10.6% a year.

Context

  • Net receivables amounted to 30.4% of total assets at the end of Q3 FY2026, down 2.8 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +3.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$25.45B+2.2% QoQ
Last fiscal yearSep 2025
$25.23B+5.7% YoY
Year agoJun 2025
$24.56B+3.6% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.6%——
1 year+5.7%——
3-year CAGR+10.6%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
25.23B USD
Year-over-year change
+5.7%
4-year CAGR
+8.2%

Net Receivables vs competitors

How COR compares with its peers on the latest reported figures

  • COR's Jun 2026 net receivables of $25.45B is the 2nd highest of the 5 companies compared; the peer median is $8.15B.
  • Its year-over-year change of +3.6% is the 4th highest of 5, against a peer median of +6.4%.
  • Net receivables amounts to 30.4% of total assets for COR, versus a peer median of 20.0%.
COR Competitors Peer median
Net Receivables for COR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MCKMcKesson CorporationJun 2026$30.32B +7.7%+13.0%34.3%
CORCencora, Inc.Jun 2026$25.45B +3.6%+10.6%30.4%
CAHCardinal Health, Inc.Sep 2026$14.54B +5.6%+7.5%24.4%
HSICHenry Schein, Inc.Jun 2026$1.76B +7.2%+4.6%15.5%
ACHAccendra Health, Inc.Mar 2026$103.7M -82.1%-49.9%4.3%
Peer median (excluding COR) $8.15B+6.4%+6.1%20.0%

Competitors are the stored peer set for COR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents2.55B3.53B2.69B3.23B4.39B
Short-term Investments00000
Net Receivables18.39B18.63B20.91B23.87B25.23B
Inventory15.37B17.09B17.45B19B20.49B
Other Current Assets2.13B342.89M1.84B1.71B2.13B
Total Current Assets38.8B39.59B42.8B47.72B52.24B
Property, Plant & Equipment (Net)3.23B3.08B3.15B3.32B4.09B
Goodwill9.03B8.5B9.57B9.32B13.68B
Intangible Assets5.26B4.33B4.43B4B3.77B
Long-term Investments060.37M63.12M66.64M0
Tax Assets290.79M237.57M200.67M246.35M208.81M
Other Non-current Assets726.81M756.32M2.34B2.43B2.6B
Total Non-current Assets18.54B16.97B19.76B19.38B24.35B
Total Assets57.34B56.56B62.56B67.1B76.59B
Account Payables38.01B40.19B45.84B50.94B54.72B
Short-term Debt475.57M1.23B823.81M781.1M371.56M
Tax Payables281.07M281.07M310.68M291.8M337.63M
Deferred Revenue00000
Other Current Liabilities2.87B2.06B2.17B2.55B2.73B
Total Current Liabilities41.36B43.48B48.83B54.28B57.82B
Long-term Debt7.33B5.5B5.07B4.84B8.96B
Deferred Tax Liabilities1.69B1.62B1.66B1.64B1.62B
Deferred Revenue (Non-current)00000
Other Non-current Liabilities5.43B5.03B5.41B4.52B5.03B
Total Non-current Liabilities15.39B13.01B13.06B12.04B17.02B
Total Liabilities56.75B56.49B61.89B66.31B74.84B
Common Stock2.91M2.93M2.95M2.96M2.97M
Retained Earnings1.67B2.98B4.32B5.42B6.53B
Accumulated OCI(445.44M)(1.83B)(1.4B)(989.12M)(901.38M)
Other Stockholders Equity00000
Minority Interest361.06M282.83M144.28M140.8M239.07M
Total Equity584.41M71.27M666.29M786.74M1.75B
Total Debt8.75B7.59B6.82B6.65B10.75B
Net Debt6.2B4.06B4.13B3.42B6.35B

Cencora, Inc.

NYSE:COR

Intrinsic Alpha fair value

Locked

Current Price

$348.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.